Secured Convertible Notes [Member] Short-term Debt, Type [Axis] Secured Convertible Notes1 [Member] Secured Convertible Notes2 [Member] Convertible note [Member] Convertible Note1 [Member] Convertible Note2 [Member] Convertible Note3 [Member] Convertible Note5 [Member] Convertible Note6 [Member] Convertible Note12 [Member] Convertible Note15 [Member] Convertible Note16 [Member] Convertible Note4 [Member] Convertible Note7 [Member] Convertible Note8 [Member] Convertible Note9 [Member] Convertible Note10 [Member] Convertible Note11 [Member] Convertible Note13 [Member] Convertible Note14 [Member] Convertible Note17 [Member] Convertible Note18 [Member] Convertible Note19 [Member] Convertible Notes I [Member] Convertible Notes II [Member] Common Stock [Member] Equity Components [Axis] Common Stock1 [Member] Common Stock2 [Member] Common Stock3 [Member] Common Stock4 [Member] Common Stock5 [Member] Common Stock6 [Member] Fair Value [Member] Hedging Relationship [Axis] Fair Value1 [Member] Fair Value2 [Member] Fair Value3 [Member] Fair Value4 [Member] Fair Value5 [Member] Fair Value6 [Member] Series B Convertible Preferred Stock Class of Stock [Axis] Series A [Member] Auction Market Preferred Securities, Stock Series [Axis] Series B [Member] SharePurchaseWarrants[Member] ConversionOption[Member] Maximum [Member] Range [Axis] Minimum [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Warrants 1 [Member] Additional Paid-In Capital Retained Earnings / Accumulated Deficit Other Comprehensive Income / Loss Common Stock Shares to be Issued Consultant Agreements [Member] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Consultant Agreements 1 [Member] Debt Instrument [Axis] Convertible Notes Payable1 [Member] Convertible Notes Payable 2 [Member] Convertible Notes Payable 3 [Member] Convertible Notes Payable 4 [Member] Convertible Notes Payable 5 [Member] Convertible Notes Payable 6 [Member] Convertible Notes Payable 7 [Member] Convertible Notes Payable 8 [Member] Convertible Notes Payable 9 [Member] Convertible Notes Payable 10 [Member] Convertible Notes Payable 1 1[Member] Convertible Notes Payable 12 [Member] Convertible Notes Payable 13 [Member] Convertible Notes Payable 14 [Member] Convertible Notes Payable 15 [Member] Convertible Notes Payable 16 [Member] Convertible Notes Payable 17 [Member] Convertible Notes Payable 18 [Member] Convertible Notes Payable 19 [Member] Convertible Notes Payable 20 [Member] Convertible Notes Payable 21 [Member] Convertible Notes Payable 22 [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash Prepaid expenses and deposits Deferred financing costs Total Current Assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable and accrued liabilities Research agreement obligations Derivative liability - conversion option Derivative liability - warrants Convertible notes payable Loans payable, related party (2013 - $5,200) Promissory notes Due to related parties Total Current Liabilities COMMITMENTS AND CONTINGENCIES Stockholders' Deficit Convertible preferred stock, $0.001 par value — 10,000,000 shares authorized: Series A, $0.001 par value, 1,250,000 shares designated, -0- shares issued and outstanding as of September 30, 2014 and December 31, 2013 Convertible preferred stock, $0.001 par value - 10,000,000 shares authorized: Series B, $0.001 par value, 1,500,000 shares designated, -0- shares issued and outstanding as of September 30, 2014 Common stock, $0.001 par value, 500,000,000 shares authorized 19,603,815 shares issued and outstanding (2013 – 1,465,712) Additional paid-in capital Shares to be issued Accumulated other comprehensive loss Accumulated deficit Total Stockholders' Deficit Total Liabilities and Stockholders' Deficit Statement [Table] Statement [Line Items] Common stock par value Common stock shares authorized Common stock shares issued Common stock shares outstanding Convertible preferred stock par value Convertible preferred stock authorized Convertible preferred stock shares designated Convertible preferred stock, issued Convertible preferred stock, outstanding Income Statement [Abstract] EXPENSES Consulting fees General and administrative Management fees Professional fees Research and development Total Expenses LOSS BEFORE OTHER ITEMS Other Income (Expense) Foreign exchange (loss) gain Changes in fair value of derivative liabilities Accretion of interest on convertible debt Interest and finance charges Loss on debt financing Loss on settlement of debt Net Loss for the Period Other comprehensive income (loss) Foreign exchange translation adjustment TOTAL COMPREHENSIVE INCOME (LOSS) BASIC AND DILUTED NET INCOME (LOSS) PER SHARE WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net loss Adjustments to reconcile net loss to net cash from operating activities: Non-cash loss on debt financing Changes in fair value of derivative liabilities Loss on settlement of debt Accretion of interest on convertible debt Stock based compensation Changes in operating assets and liabilities: Prepaid expenses and deposits Deferred financing costs Accounts payable and accrued liabilities Research agreement obligations NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES Issuance of shares, net Convertible notes, net Proceeds from loans payable Repayment of promissory notes Advances from (to) related parties NET CASH PROVIDED BY FINANCING ACTIVITIES INCREASE (DECREASE) IN CASH CASH, BEGINNING OF PERIOD CASH, END OF PERIOD Supplemental cash flow information and non-cash investing and financing activities: Conversion of convertible debt, accounts payable, loan, promissory notes, and accrued interest Beginning Balance Shares Beginning Balance Amount Convertible notes, promissory notes, loan and accrued interest converted into common stock Shares Convertible notes, promissory notes, loan and accrued interest converted into common stock amount Conversion of accounts payable to common stock Share Conversion of accounts payable to common stock amount Private placement (net of finders’ fee) Shares Private placement (net of finders’ fee) amount Foreign exchange translation adjustment Stock- based compensation Shares Stock- based compensation amount Net loss Ending Balance Shares Ending Balance Amount Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS BASIS OF PRESENTATION Notes to Financial Statements LIQUIDITY AND FINANCIAL CONDITION Accounting Policies [Abstract] SIGNIFICANT ACCOUNTING POLICIES Payables and Accruals [Abstract] ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Research and Development [Abstract] RESEARCH AGREEMENTS DERIVATIVE WARRANT LIABILITY AND FAIR VALUE Debt Disclosure [Abstract] CONVERTIBLE NOTES PAYABLE LOANS PAYABLE Equity [Abstract] PROMISSORY NOTES, RELATED PARTY Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS CAPITAL STOCK Supplemental Cash Flow Elements [Abstract] SUPPLEMENTAL CASH FLOW INFORMATION AND NON-CASH INVESTING AND FINANCING ACTIVITIES Commitments and Contingencies Disclosure [Abstract] CONTINGENCIES AND COMMITMENTS Subsequent Events [Abstract] SUBSEQUENT EVENTS Recently Issued Accounting Pronouncements Debt instrument transactions Share Purchase Warrants Debt settlements Accounts Payable and Accrued Liabilities Schedule of cash flow supplemental Additional disclosure on non-cash transactions Warrants and conversion option Derivative liability - warrants and Derivative liability - conversion option Financial assets and liabilities Trade accounts payable Debt settlement accruals Accrued liabilities Employee payroll and severance Accrued interest Total accounts Payable and Accrued Liabilities Accrued liablities Expected Life (Years) Risk free Rate Dividend yield Volatility Derivative liability - conversion option Total Balance – December 31, 2013 Loss on settlement of debt Change in fair value of conversion option liability Change in fair value of warrant liability Balance – September 30, 2014 Issue Date Maturity Date Interest Rate Conversion Terms Principal Balance September Principal Balance December Total convertible notes Unamortized note discount Total on Balance sheet Principal amount Common shares Remaining balance Settlement and recognized repaid Gain on settlement of debt Debt discount Unsecured loan advances amount Investors converted Related party converted Accrued interest Post reverse stock split common shares Fair value of shares Loss on settlement of debt Cost incurred Amounts of owing directors and officers fees Management fees Research and development services Stock based compensation Cost recorded Note converted Debt due to related parties Payable into convertible notes Consulting agreements Amount Consulting agreements Obligation to Issue Number of Shares Debt settlement Amount Debt settlement Obligation to Issue Number of Shares Number of Warrants Balance, December 31, 2013 Issued Exercised Extinguished or expired Balance, September 30, 2014 Weighted Average Exercise Price Balance, December 31, 2013 Issued Exercised Extinguished or expired Balance, September 30, 2014 Weighted Average Remaining Life Balance, December 31, 2013 Issued Exercised Extinguished or expired Balance, September 30, 2014 Received subscription proceeds1 Received subscription proceeds Preferred stock Shares of common stock Fair value Accrued interest Related parties converted Accounts payable and loan shares Fair value of approximately Stock based consulting and management fees Grant shares Issued common shares Shares issued at fair value Expensed during the period Cash and cash equivalents Shares granted during the option activity. Assets, Current Deferred Tax Assets, in Process Research and Development Derivative Assets (Liabilities), at Fair Value, Net Loans and Leases Receivable, Gross, Commercial Due from Related Parties Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Other Expenses Other Comprehensive Income (Loss), before Tax Accretion of Discount Gain (Loss) on Sales of Loans, Net Life Settlement Contracts, Fair Value Method, Gain (Loss) Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Deferred Charges Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Repayments of Convertible Debt Payments to Fund Long-term Loans to Related Parties Net Cash Provided by (Used in) Financing Activities Cash, Period Increase (Decrease) Foreign Currency Translation Adjustment, Description Debt Instrument, Periodic Payment Increase (Decrease) in Accounts Payable Management Fee Payable Stock Granted, Value, Share-based Compensation, Gross Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Exercised [Default Label] ExtinguishedOrExpired Debt Instrument, Increase, Accrued Interest